TransMedics: Exceptional Q1 Undermines The Short Narrative

TransMedics's ( TMDX ) Q1 results were extremely strong across the board, which is no surprise for anyone that has been tracking transplant volumes and flight activity. While growth could exhibit volatility from quarter to quarter, and competition will increase in the nearRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be a ...